The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...

North Carolina is listed as a location for the manufacture of AstraZeneca and Sanofi's respiratory syncytial virus (RSV) prevention antibody, nirsevimab, as well as for GSK's two-drug HIV regimen ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

ABL Bio has announced a global licensing agreement with GSK, allowing the latter to develop medicines for neurodegenerative ...